Location History:
- Kiel, DE (2013)
- Neuss, DE (2015)
Company Filing History:
1 out of 18 
1 out of 13 Years Active: 2013-2015
Title: The Innovative Mind of Jürgen Scheller
Introduction
Jürgen Scheller, based in Neuss, Germany, is a distinguished inventor whose contributions to the field of biotechnology have paved the way for advanced medical treatments. With a proven track record of two patents, Scheller's work primarily focuses on ciliary neurotrophic factors and soluble GP130 muteins, both of which are vital in understanding and addressing various medical conditions.
Latest Patents
Scheller's latest patents showcase his innovative approach to biotechnology. The first patent involves ciliary neurotrophic factor variants, detailing a nucleic acid molecule with defined sequences that encode peptides capable of binding to the ciliary neurotrophic factor receptor with lower affinity than the natural ciliary neurotrophic factor. This inventive molecular design aims to create therapeutic agents that can interact more selectively with the interleukin-6 receptor.
His second patent focuses on soluble GP130 muteins with improved binding activity. It describes polypeptide monomers and dimers with specific amino acid mutations intended to enhance the binding affinity of gp130 to its ligand complex, which includes interleukin-6 and soluble interleukin-6 receptor. The triple mutein identified in this patent demonstrates a significant increase in biological activity, making it a promising candidate for pharmaceutical applications.
Career Highlights
Throughout his career, Jürgen Scheller has made significant contributions to research, notably through his work at Christian-Albrechts-University of Kiel and Conaris Research Institute AG. His role in these prestigious institutions has allowed him to conduct ground-breaking research and develop technologies that advance our understanding of intercellular communication in the immune system.
Collaborations
Scheller has collaborated with prominent scientists in the field, including Joachim Grötzinger and Stefan Rose-John. These partnerships have enriched his research and facilitated the exchange of innovative ideas, leading to advancements in therapeutic strategies centered around the interleukin-6 pathway.
Conclusion
Jürgen Scheller's contributions to biotechnology exemplify the spirit of innovation essential in the medical field. His patents on ciliary neurotrophic factor variants and soluble GP130 muteins highlight his commitment to advancing medical knowledge and developing novel treatments. With a rich career marked by collaboration and research excellence, Scheller continues to be a driving force in the realm of biotech inventions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.